SBH
Sally BeautyAAI scenario view
RankAlpha Sentiment CodexThe current persistence contract does not provide an exact AI reference price. RankAlpha therefore does not calculate scenario return from the live quote. How scenarios are presented
AI sentiment snapshot
AI commentary
Primary-source Q3 evidence is mixed: stronger Sally U.S. and Canada sales, margin and cash flow contrast with flat consolidated comparable sales and weaker Beauty Systems Group results. Recent packet coverage is thin. The numeric sentiment fields are unavailable placeholders, not measured readings; no verified recent price reaction, analyst revisions, options skew, short-interest reading, employee score or sufficient social sample was supplied. [#SEC-8K-2026-08-03]
Evidence flagged
No evidence quality warning is currently attached to this memo.
AI events
The Q3 earnings exhibit narrowed fiscal 2026 guidance to $3.725–$3.733 billion in sales, $329–$335 million in adjusted operating earnings, and $2.04–$2.08 in adjusted diluted EPS. Full-year results will test whether margin gains and cash generation persisted. The reporting date is unconfirmed; the expected date is a monitoring deadline, not a company announcement. [#8-K-2026-08-03] [#SEC-8K-2026-08-03]
Beauty Systems Group Q3 sales declined 2.4% and comparable sales declined 2.1%. Continued weakness could offset Sally Beauty gains and limit consolidated growth. [#SEC-8K-2026-08-03]
Management reported 3.5% comparable-sales growth in Sally U.S. and Canada and 11% global e-commerce growth in Q3. Sustained gains would matter more if they lift consolidated comparable sales, which were flat in Q3. [#SEC-8K-2026-08-03]
Recommendation
No formal recommendation provided.

